MARCY-L’ETOILE, France (Reuters) – French drugmaker Sanofi on Tuesday said it would invest 610 million euros ($679.4 million) at two of its French sites to turn them into a hub dedicated to research, development and production of vaccines.
Investments will help enhance the capacities of the group’s sites at Marcy-L’Etoile and Neuville-sur-Saone, central France.
The announcement came as Sanofi officials hosted a visit of French president Emmanuel Macron at Sanofi’s Marcy-L’Etoile facility on Tuesday.
(Reporting by Gonzalo Fuentes; Writing by Matthias Blamont; Editing by Sudip Kar-Gupta and Louise Heavens)
